Terms: = Sarcomas AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Treatment
11 results:
1. LINC00629 protects osteosarcoma cell from ER stress-induced apoptosis and facilitates tumour progression by elevating klf4 stability.
Wang Y; Zheng S; Han J; Li N; Ji R; Li X; Han C; Zhao W; Zhang L
J Exp Clin Cancer Res; 2022 Dec; 41(1):354. PubMed ID: 36539799
[TBL] [Abstract] [Full Text] [Related]
2. CRISPR/Cas9-mediated overexpression of long non-coding RNA SRY-box transcription factor 21 antisense divergent transcript 1 regulates the proliferation of osteosarcoma by increasing the expression of mechanistic target of rapamycin kinase and Kruppel-like factor 4.
Zhang W; Wang Q; Du H; Jiang S
Bioengineered; 2022 Mar; 13(3):6678-6687. PubMed ID: 34696664
[TBL] [Abstract] [Full Text] [Related]
3. A multimodal treatment of carbon ions irradiation, miRNA-34 and mTOR inhibitor specifically control high-grade chondrosarcoma cancer stem cells.
Vares G; Ahire V; Sunada S; Ho Kim E; Sai S; Chevalier F; Romeo PH; Yamamoto T; Nakajima T; Saintigny Y
Radiother Oncol; 2020 Sep; 150():253-261. PubMed ID: 32717360
[TBL] [Abstract] [Full Text] [Related]
4. Mechanisms underlying the promotion of osteosarcoma cell proliferation and invasion by lncRNA PBB12.
Ma T; Liu A; Xu D; Zhang T
Oncol Rep; 2020 Feb; 43(2):736-746. PubMed ID: 31894336
[TBL] [Abstract] [Full Text] [Related]
5. klf4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells.
Qi XT; Li YL; Zhang YQ; Xu T; Lu B; Fang L; Gao JQ; Yu LS; Zhu DF; Yang B; He QJ; Ying MD
Acta Pharmacol Sin; 2019 Apr; 40(4):546-555. PubMed ID: 29930276
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of klf4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
Li Y; Xian M; Yang B; Ying M; He Q
Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
[TBL] [Abstract] [Full Text] [Related]
7. miR-10b promotes invasion by targeting klf4 in osteosarcoma cells.
Wang J; Wang B; Chen LQ; Yang J; Gong ZQ; Zhao XL; Zhang CQ; Du KL
Biomed Pharmacother; 2016 Dec; 84():947-953. PubMed ID: 27764757
[TBL] [Abstract] [Full Text] [Related]
8. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.
Kelleher FC; O'Sullivan H
Oncotarget; 2016 Jul; 7(27):42792-42804. PubMed ID: 27074562
[TBL] [Abstract] [Full Text] [Related]
9. Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
Huang J; Liu K; Song D; Ding M; Wang J; Jin Q; Ni J
Cancer Sci; 2016 Mar; 107(3):242-9. PubMed ID: 26676883
[TBL] [Abstract] [Full Text] [Related]
10. Reprogramming cancer cells: back to the future.
Lang JY; Shi Y; Chin YE
Oncogene; 2013 May; 32(18):2247-8. PubMed ID: 22869153
[TBL] [Abstract] [Full Text] [Related]
11. Gene expression profiling in sarcomas.
Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
[TBL] [Abstract] [Full Text] [Related]
